Dr Amanda Roxburgh

Dr Amanda Roxburgh (MPsychol [Clin] PhD MAPS) is a Senior Research Fellow and Clinical Psychologist.

Amanda has over 20 years' experience in the alcohol and other drug research sector and has a national and emerging international profile relating to her expertise in opioid overdose mortality. She has published over 50 scientific publications and delivered more than 70 national and international conference presentations.  Her work is published in leading international journals.

Her research has led to a greater understanding of the changing nature of opioid overdose mortality and the contribution of pharmaceutical opioids to these deaths. 

Amanda's work has informed legislative change in Australia (e.g. rescheduling of codeine and regulatory changes in dispensing of Schedule 8 opioids). She has led briefings to government (e.g. the Australian Government Department of Health, and the Pharmaceutical Board Advisory Committee). Written commissioned (by the Intergovernmental Committee on Drugs – IGCD and the NSW Parliament) reports which have directly informed Australia's National Drug Strategy.

Her current research focuses on understanding the factors driving non-fatal and fatal overdose in the context of contemporary drug markets, with the aim of informing overdose policy responses and reducing drug-related harms.

Amanda has developed strong collaborative partnerships within the sector, working with the Uniting Medically Supervised Injecting Centre in Sydney, the Medically Supervised Injecting Room in Melbourne, the Discipline of Addiction Medicine at the University of Sydney, Monash University, and the National Drug and Alcohol Research Centre, University of New South Wales.

Primary Supervisor for:

• Oisin Stornach

Co-supervisor for:

• Bianca Whiteside
• Shady Abdelsalam

National Health and Medical Research Council, Australia (including Investigator Grant and Partnership Grant)

Australian Government Dept of Health and Ageing, NSW Ministry of Health, NHMRC, Deakin University, Network of Alcohol and other Drug Agencies

• 2019: PhD, University of New South Wales Australia
• 2007: MPsychol (Clin), University of New South Wales, Australia
• 2001: BA Hons (Psychology and Sociology) University of Sydney, Australia
• 1998: Masters of Criminology, University of Sydney, Australia

• Research Affiliate, Discipline of Addiction Medicine, University of Sydney, Sydney, Australia
• Adjunct Research Fellow, Monash Addiction Research Centre (MARC) and School of Public Health and Preventive Medicine (SPHPM), Monash University, Melbourne
• Adjunct Fellow, National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Sydney, Australia
• Full member of the Australian Psychological Society and the College of Clinical Psychologists
• Full Member of the Australasian Professional Society on Alcohol and other Drugs

• 2023: Shortlisted for L’oreal Women in Science Award; Shortlisted for USyd Horizons Fellowship
• 2022: Cass Foundation Travel Award
• 2019: Deans Award for outstanding PhD, conferred by Faculty of Medicine, University of New South Wales
• 2013: The Jen McLaren Award for outstanding research contribution, conferred by the National Drug and Alcohol Research Centre, University of New South Wales
• 2013: Deans Award for Professional and Technical staff for outstanding research contribution, conferred by Faculty of Medicine, University of New South Wales

• July 2023: National Health and Medical Research Council (NHMRC) Senior Research Fellow, Burnet Institute
• 2020-Jun 2023: National Health and Medical Research Council (NHMRC) Research Fellow, Burnet Institute
• 2004-2019: Senior Research Officer National Drug and Alcohol Research Centre, Epidemiology and Surveillance (NDARC).
• 2002-2004: Research Officer, Drug Trends program, NDARC.